成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

<form id="t8r3h"><dl id="t8r3h"></dl></form><i id="t8r3h"></i>
<rt id="t8r3h"></rt>
    • <td id="t8r3h"></td>
      <strike id="t8r3h"><big id="t8r3h"><delect id="t8r3h"></delect></big></strike>
      <samp id="t8r3h"><dl id="t8r3h"><delect id="t8r3h"></delect></dl></samp>
      <var id="t8r3h"></var>
      <code id="t8r3h"></code>
    • Doxorubicin hydrochloride

      Doxorubicin hydrochloride Struktur
      25316-40-9
      CAS-Nr.
      25316-40-9
      Bezeichnung:
      Doxorubicin hydrochloride
      Englisch Name:
      Doxorubicin hydrochloride
      Synonyma:
      DOX;DOXORUBICIN HCL;ADR;Doxorubicin HCI;CAELYX;DOX HCl;DOX HYDROCHLORIDE;ADRIAMYCIN HYDROCHLORIDE;(8s-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride;(8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
      CBNumber:
      CB0110633
      Summenformel:
      C27H29NO11.ClH
      Molgewicht:
      579.98
      MOL-Datei:
      25316-40-9.mol

      Doxorubicin hydrochloride Eigenschaften

      Schmelzpunkt:
      216 °C (dec.)(lit.)
      alpha 
      D20 +248±2° (c = 0.1 in methanol)
      storage temp. 
      2-8°C
      L?slichkeit
      Soluble in DMSO at 100 mg/ml; very poorly soluble in ethanol; soluble in water at 10 mg/ml with slight warming.
      pka
      pKa 8.25±0.60 (Uncertain);8.43±0.70 (Uncertain);11.9±0.4 (Uncertain);12.95±0.1 (Uncertain);13.8±0.70 (Uncertain)
      Aggregatzustand
      solid
      Farbe
      orange to dark red
      Biologische Quelle
      synthetic (organic)
      Wasserl?slichkeit
      Soluble in water.
      maximale Wellenl?nge (λmax)
      497nm(H2O)(lit.)
      Merck 
      14,3439
      BRN 
      4229251
      Stabilit?t:
      Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 3 months.
      InChIKey
      MWWSFMDVAYGXBV-RUELKSSGSA-N
      CAS Datenbank
      25316-40-9(CAS DataBase Reference)
      EPA chemische Informationen
      Doxorubicin hydrochloride (25316-40-9)
      Sicherheit
      • Risiko- und Sicherheitserkl?rung
      • Gefahreninformationscode (GHS)
      Kennzeichnung gef?hrlicher T,T+,Xi
      R-S?tze: 45-22-40-26/27/28-36/38
      S-S?tze: 53-45-36/37/39-22-7/9
      WGK Germany  3
      RTECS-Nr. QI9295900
      10-21
      HS Code  29419090
      Toxizit?t LD50 i.v. in mice: 21.1 mg/kg (Bertazzoli, 1970)
      Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
      Alarmwort Achtung
      Gefahrenhinweise
      Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
      H302 Gesundheitssch?dlich bei Verschlucken. Akute Toxizit?t oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
      H340 Kann genetische Defekte verursachen. Keimzellmutagenit?t Kategorie 1B Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
      H350 Kann Krebs verursachen. Karzinogenit?t Kategorie 1A Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
      Sicherheit
      P201 Vor Gebrauch besondere Anweisungen einholen.
      P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
      P264 Nach Gebrauch gründlich waschen.
      P264 Nach Gebrauch gründlich waschen.
      P270 Bei Gebrauch nicht essen, trinken oder rauchen.
      P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
      P308+P313 BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen.

      Doxorubicin hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

      R-S?tze Betriebsanweisung:

      R45:Kann Krebs erzeugen.
      R22:Gesundheitssch?dlich beim Verschlucken.
      R40:Verdacht auf krebserzeugende Wirkung.
      R26/27/28:Sehr giftig beim Einatmen, Verschlucken und Berührung mit der Haut.

      S-S?tze Betriebsanweisung:

      S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen.
      S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
      S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
      S22:Staub nicht einatmen.
      S7/9:Beh?lter dicht geschlossen an einem gut gelüfteten Ort aufbewahren.

      Chemische Eigenschaften

      Doxorubicin is an orange to red cake-like or needle-like crystalline solid. It is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius. Doxorubicin hydrochloride is an orange-red, crystalline, hygroscopic powder that is soluble in water and slightly soluble in methanol.

      Verwenden

      Doxorubicin hydrochloride (adriamycin hydrochloride) is an antitumour agent that has been formulated as a salt to achieve higher water solubility. While the salt shares the same pharmacological properties as doxorubicin free base, its greater water solubility may offer advantages in some in vitro applications. Physicochemical properties and chromatographic behaviour will depend on whether the pH is buffered. In non-pH controlled systems the free base and salt may behave differently.

      Biologische Funktion

      The C13 substituent of doxorubicin is hydroxymethyl, which retards the action of cytosolic aldoketoreductase and slows the conversion to the equally active, but chronically cardiotoxic, doxorubicinol.

      Allgemeine Beschreibung

      Adriamycin hydrochloride appears as orange-red thin needles. Aqueous solutions yellow-orange at acid pHs, orange-red at neutral pHs, and violet blue over pH 9. Doxorubicin is available as both the conventional dosageform and a liposomal preparation, both of which are administeredby infusion. Doxorubicin HCl powder is available in10-, 20-, 50-, and 150-mg vials and is widely used in treatingvarious cancers, including leukemias, soft and bone tissuesarcomas, Wilms tumor, neuroblastoma, small cell lungcancer, and ovarian and testicular cancer.

      Air & Water Reaktionen

      Water soluble.

      Reaktivit?t anzeigen

      Amines, like Doxorubicin hydrochloride, are weak chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.

      Brandgefahr

      Doxorubicin hydrochloride is probably combustible.

      Biologische Aktivit?t

      Antitumor antibiotic agent that inhibits DNA topoisomerase II. DNA intercalator that inhibits nucleic acid synthesis and induces apoptosis.

      Mechanism of action

      Liposomes are taken up selectively into tumor cells, presumably because of their persistence in the bloodstream and enhanced permeability of tumor vascular membranes. In liposomal form, the drug is protected against enzymes that generate cardiotoxic free radicals, although this form of the drug can still induce potentially fatal congestive heart failure. Clinical experience with the liposomal formulation is limited, and few studies comparing the long-term toxicity with that of conventional doxorubicin therapy have been conducted. Therefore, all precautions outlined for the use of doxorubin also are employed when the liposomal formulation is used.

      Clinical Use

      Doxorubicin is utilized either alone or in combination therapy to treat a wide range of neoplastic disorders, including hematologic cancers and solid tumors in breast, ovary, stomach, bladder, and thyroid gland. A liposomal formulation of doxorubicin is used in the treatment of AIDS-related Kaposi's sarcoma and organoplatinum-resistant ovarian cancer.

      m?gliche Exposition

      An antibiotic product from streptomyces, used as anticancer drug

      Stoffwechsel

      This contributes to the longer duration of action compared to analogues that have CH3 at this position (e.g., daunorubicin). Doxorubicin is highly lipophilic and concentrates in the liver, lymph nodes, muscle, bone marrow, fat, and skin. Elimination is triphasic, and the drug has a terminal half-life of 30 to 40 hours. The majority of an administered dose is excreted in the feces.

      Versand/Shipping

      UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required.

      Inkompatibilit?ten

      Incompatible with oxidizers (chlorates, nitrates, peroxides, permanganates, perchlorates, chlorine, bromine, fluorine, etc.); contact may cause fires or explosions. Keep away from alkaline materials, strong bases, strong acids, oxoacids, epoxides

      Waste disposal

      It is inappropriate and possibly dangerous to the environment to dispose of expired or waste pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consideration applicable DEA, EPA, and FDA regulations. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.

      Doxorubicin hydrochloride Upstream-Materialien And Downstream Produkte

      Upstream-Materialien

      Downstream Produkte


      Doxorubicin hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

      Global( 803)Lieferanten
      Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
      Beijing Mesochem Technology Co.,Ltd
      +8613651027935
      rachel@mesochem.com China 191 58
      Hebei Chuanghai Biotechnology Co., Ltd
      +8615531157085
      abby@chuanghaibio.com China 8808 58
      Shaanxi Dideu Medichem Co. Ltd
      +86-29-81148696 +86-15536356810
      1022@dideu.com China 3883 58
      Hebei Mujin Biotechnology Co.,Ltd
      +86 13288715578 +8613288715578
      sales@hbmojin.com China 12809 58
      Sinoway Industrial co., ltd.
      0592-5800732; +8613806035118
      xie@china-sinoway.com China 987 58
      Hebei Dangtong Import and export Co LTD
      +86-86-4001020630 +8619831957301
      admin@hbdangtong.com China 998 58
      Hebei Fengjia New Material Co., Ltd
      +86-0311-87836622 +86-18712993135
      sales01@tairunfaz.com China 8051 58
      Henan Bao Enluo International TradeCo.,LTD
      +86-17331933971 +86-17331933971
      deasea125996@gmail.com China 2472 58
      Anhui Ruihan Technology Co., Ltd
      +8617756083858
      daisy@anhuiruihan.com China 973 58
      Henan Fengda Chemical Co., Ltd
      +86-371-86557731 +86-13613820652
      info@fdachem.com China 20235 58

      25316-40-9(Doxorubicin hydrochloride)Verwandte Suche:


      • ADRIACIN
      • ADRIBLASTINA
      • ADRIBLASTINA HYDROCHLORIDE
      • ADRIAMYCIN HCL
      • 14-HYDROXYDAUNOMYCIN HCL
      • 14-HYDROXYDAUNOMYCIN HYDROCHLORIDE
      • DOXORUBICIN HYDROCHLORIDE
      • HYDROXYDAUNORUBICIN HYDROCHLORIDE
      • (8s-cis)-hlorid
      • DOXORUBICIN HYDROCHLORIDE, FOR FLUORESCE NCE
      • DOXORUBICIN HYDROCHLORIDE SOLUTION 2 MG/
      • DOXORUBICIN HYDROCHLORIDE 98+%
      • DOXORUBICIN HCL/ DOXORUBICIN HYDROCHLORIDE
      • DoxorubicinHcl,Usp28
      • (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
      • Caely
      • Adriamycin HCl Solution
      • 5,12-Naphthacenedione, 10-(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
      • DOXORUBICINHCL(FDA)
      • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
      • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
      • Adriamycin, hydrochloride (8CI)
      • Adriblastina RD
      • FI 106
      • Lipodox
      • DOXORUBICIN HYDROCHLORIDE WITH EXTENDER AND PRESERVA
      • DOXORUBICIN HYDROCHLORIDE (ADRIAMYCIN HC L) \ APOPTOSIS INDUCER
      • Doxorubicin HCl(BICINS)
      • Doxorubicin Hydrochloride /Adriamycin hydrochloride
      • (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
      • 14-hydroxyribomycin
      • Doxorubicin (AdriaMycin)
      • Doxorubicin hydrochlorid
      • Doxorubicin hydrochloride solution
      • Doxorubicin Hydrochloride for Injection
      • Doxorubicin hydrochloride, >=99%
      • Doxorubicin HCL/Adriamycin HCL
      • Doxorubicin hydrochloride(DOX)
      • (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-tri
      • 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-12-naphthacenedione
      • 8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-xy)-hydroc
      • admhydrochloride
      • Ardriamycin
      • fi6804
      • Adriamycin(R) hydrochloride, DOX, Hydroxydaunorubicin hydrochloride
      • Doxorubicin solution hydrochloride
      • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
      • Adriblastin hydrochloride
      • Doxorrubicin Hydrochloride
      • (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid) hydrochloride
      • 10-[(3-Amino-2,3,6-trideoxy-α-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedionehydrochloride
      • Doxorubicin Hydrochloride (50 mg)
      • Doxorubicin hydrochl
      • Doxorubicin hydrochloride((AdriaMycin)
      • Doxorubicin Hydrochloride, USP
      • Doxorubicin HCl/AdriaMycin
      • Doxorubicin hydrochloride,Adriamycin hydrochloride, DOX, Hydroxydaunorubicin hydrochloride
      • (8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-aMino-5-hydroxy-6-Methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-Methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
      Copyright 2019 ? ChemicalBook. All rights reserved